BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.70
+0.05 (0.16%)
Apr 2, 2025, 1:30 PM CST

BioGend Therapeutics Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-116.47-156.33-184.46-138.49-145.59
Upgrade
Depreciation & Amortization
51.1955.0253.1828.1919.19
Upgrade
Loss (Gain) From Sale of Assets
----0.48
Upgrade
Loss (Gain) From Sale of Investments
----26.7-
Upgrade
Loss (Gain) on Equity Investments
2.46-10.34-11.3514.24
Upgrade
Stock-Based Compensation
3.64----
Upgrade
Other Operating Activities
-13.02-13.1-29.26-5.81-0.35
Upgrade
Change in Accounts Receivable
-20.67-15.42-6.22-4.720.03
Upgrade
Change in Inventory
0.58-11.654.131.38-7.9
Upgrade
Change in Accounts Payable
2.060.081.6-0.880.3
Upgrade
Change in Unearned Revenue
-2.5----
Upgrade
Change in Other Net Operating Assets
-16.1713.022.23-1.122.48
Upgrade
Operating Cash Flow
-98.91-138.72-168.78-136.8-117.13
Upgrade
Capital Expenditures
-0.65-26.04-18.18-0.67-0.2
Upgrade
Cash Acquisitions
---26.41-
Upgrade
Sale (Purchase) of Intangibles
-0.32---
Upgrade
Investment in Securities
-6.24-64223.2-159.97-112.99
Upgrade
Other Investing Activities
-1.310.08-3.32-0.04-0.32
Upgrade
Investing Cash Flow
-8.2-89.64201.7-134.27-113.51
Upgrade
Long-Term Debt Repaid
-3.64-3.58-4.81-1.78-
Upgrade
Net Debt Issued (Repaid)
-3.64-3.58-4.81-1.78-
Upgrade
Issuance of Common Stock
-400-289.63260
Upgrade
Other Financing Activities
----0.9
Upgrade
Financing Cash Flow
-3.64396.42-4.81287.85260.9
Upgrade
Foreign Exchange Rate Adjustments
-0.74-1.19-0.79-0.49-
Upgrade
Net Cash Flow
-111.49166.8727.3216.2830.27
Upgrade
Free Cash Flow
-99.56-164.76-186.96-137.47-117.33
Upgrade
Free Cash Flow Margin
-59.38%-149.91%-594.54%-1483.13%-8422.90%
Upgrade
Free Cash Flow Per Share
-0.81-1.37-1.81-1.36-1.34
Upgrade
Cash Interest Paid
0.220.260.090.020.01
Upgrade
Cash Income Tax Paid
0.50.2-0.18-0.12
Upgrade
Levered Free Cash Flow
-57.11-95.39-98.09-83.82-69.96
Upgrade
Unlevered Free Cash Flow
-56.97-95.23-98.04-83.81-69.96
Upgrade
Change in Net Working Capital
34.7314.19-3.978.635.44
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.